November 2010 - Therapeutic Effects of Human STRO-3-Selected Mesenchymal Precursor Cells and their Soluble Factors in Experimental Myocardial Ischemia
September 2010 - Reparative Effects of Allogeneic Mesenchymal Precursor Cells Delivered Transendocardially in Experimental Nonischemic Cardiomyopathy
May 2010 - Enrichment for STRO-1 Expression Enhances the Cardiovascular Paracrine Activity of Human Bone Marrow-Derived Mesenchymal Cell Populations
1 October 2009 - Mesenchymal Cell Transplantation and Myocardial Remodeling After Myocardial Infarction
March 2009 - Allogeneic Mesenchymal Precursor Cell Therapy to Limit Remodeling After Myocardial Infarction: The Effect of Cell Dosage
March 2006 - Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium
The American Heart Association estimates 80 million American adults (approximately 1 in 3) have one or more forms of cardiovascular diseases...
Stem cell therapy is emerging as the new paradigm for treating and potentially curing human disease. It involves the use of living cells...
Mesoblast is aiming to produce therapeutics for the treatment of heart conditions, blood vessel diseases of the eyes and legs bone marrow regeneration after cancer...
